Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Robert Pattinson Cast as the Next James Bond

    November 16, 2026

    US tightens AI chip export controls to deter Chinese companies from accessing compute remotely | TechCrunch

    November 16, 2026

    Garrick Merrifield Resurfaces With AI Harem Of Wives, Cult Vibes

    November 16, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»There’s New Proof Crispr Can Edit Genes Inside Human Bodies
    Science

    There’s New Proof Crispr Can Edit Genes Inside Human Bodies

    By AdminSeptember 22, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    There’s New Proof Crispr Can Edit Genes Inside Human Bodies

    [ad_1]

    The Crispr components can’t naturally get into cells on their own, so Intellia uses a delivery system called lipid nanoparticles—essentially tiny fat bubbles—to ferry them to the liver. In Intellia’s trials, patients receive a one-time IV infusion of these Crispr-laden nanoparticles into the veins in their arms. Since blood passes through the liver, lipid nanoparticles can easily travel there from the bloodstream. In the liver, the nanoparticles are taken up by cells called hepatocytes. Once inside these cells, the nanoparticles break down and let Crispr get to work editing out the problematic gene.

    In both diseases, a genetic mutation allows an aberrant protein to run amok and cause damage. In hereditary angioedema, Intellia’s Crispr treatment is designed to knock out the KLKB1 gene in liver cells, which reduces the production of kallikrein protein. Too much kallikrein leads to the overproduction of another protein, called bradykinin, which is responsible for recurring, debilitating, and potentially fatal swelling attacks.

    According to an Intellia press release, before receiving a Crispr infusion, patients experienced one to seven swelling attacks per month. During a 16-week observational period, the Crispr infusion reduced those attacks by an average of 91 percent.

    In transthyretin amyloidosis, mutations in the TTR gene cause the liver to produce abnormal versions of the transthyretin protein. These damaged proteins build up over time, causing serious complications in tissues including the heart, nerves, and digestive system. One type of the disease can lead to heart failure and affects between 200,000 to 500,000 people worldwide. By the time patients are diagnosed with the disease, they’re expected to live just two to six more years.

    Intellia’s Crispr treatment is designed to inactivate the TTR gene and reduce the buildup of the disease-causing protein it makes. Vaishali Sanchorawala, director of the Amyloidosis Center at the Boston University School of Medicine, says the reduction that Intellia is reporting is exciting. “This has the potential to completely revolutionize the outcome for these patients who live with this disease,” Sanchorawala says.

    One big question is whether the edits will be permanent. In some of the patients, Crispr is showing promise over a year out, says Leonard. But liver cells eventually regenerate, and scientists haven’t followed patients long enough to know whether new cells that split off from the edited ones will also harbor the genetic correction.

    “What we know is that when you edit a cell, it will stay edited for its life. There’s no way to undo that. And then if there’s turnover, the question is: Well, where do the new cells come from? In the case of the liver, it comes from other hepatocytes,” says Leonard. “We think once you’ve got it in the upstream cell from which everything else follows, it’s forever.”

    Scientists working on in vivo Crispr therapies have zeroed in on the liver as an initial target because many genetic diseases are associated with it. And because fats such as lipids are readily absorbed by the liver, scientists at Intellia and elsewhere have figured out that they can be used to deliver Crispr there.

    Two other companies, Beam Therapeutics and Verve Therapeutics, are also using lipid nanoparticles to target the liver with gene editing. In July, Verve began a trial to treat a genetic form of high cholesterol with base editing, a more precise form of Crispr.

    But Leonard points out that getting Crispr to other cells and organs is still a conundrum. “Where it’s hard to get to is the brain and the lungs,” says Leonard. “When you think about the years ahead, those are the areas where standard lipid nanoparticle technology might not work and you may need other systems.”

    Where Crispr will go next will depend on where researchers can send it.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleWolverine Game Comes Early In Marvel’s Spider-Man Mod
    Next Article The Ungodly Surveillance of Anti-Porn ‘Shameware’ Apps

    RELATED POSTS

    Climate Change Has Pushed the World's Ice Out of Its Safe Zone

    November 12, 2026

    Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

    November 12, 2026

    The Polar Vortex Is About to Make Weather Weird From the UK to the US

    November 12, 2026

    A Startup Wants to Fight AI Bioweapons With AI

    November 11, 2026

    Michigan Residents Voted to Get Corporate Money Out of Politics. Now Utilities Are Suing

    November 11, 2026

    A New Benchmark for De-Aging Comes From Slowly Turning Back Cells Clocks

    November 11, 2026
    latest posts

    Robert Pattinson Cast as the Next James Bond

    After literal years of speculation and dozens of names being mentioned, director Denis Villeneuve has…

    US tightens AI chip export controls to deter Chinese companies from accessing compute remotely | TechCrunch

    November 16, 2026

    Garrick Merrifield Resurfaces With AI Harem Of Wives, Cult Vibes

    November 16, 2026

    Karol G Postpones Show in Mexico City Due to Health Reasons: Heres the New Date

    November 16, 2026

    Angels & Demons: Ken Russell's The Devils

    November 15, 2026

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    6 Golden Age Westerns To Watch On Prime Video (That Dont Star John Wayne)

    November 15, 2026
    Categories
    • Books (1,590)
    • Business (6,481)
    • Events (85)
    • Film (6,450)
    • Lifestyle (4,502)
    • Music (6,583)
    • Politics (6,447)
    • Science (5,851)
    • Technology (6,438)
    • Television (6,142)
    • US News (6,486)
    popular posts

    Neurons in a Dish Learn to Play Pong

    [ad_1] Hundreds of thousands of human neurons growing in a dish coated with electrodes have…

    Zac Efron, John Cena in Peter Farrelly Comedy

    March 6, 2024

    Driver of Cybertruck ‘Shot Himself in Head’ Before Vegas Explosion

    January 6, 2025

    25 Of The Best Men’s Luxury Watches To Show Up In Style And In Time (Updated 2022)

    September 17, 2022
    Archives
    Browse By Category
    • Books (1,590)
    • Business (6,481)
    • Events (85)
    • Film (6,450)
    • Lifestyle (4,502)
    • Music (6,583)
    • Politics (6,447)
    • Science (5,851)
    • Technology (6,438)
    • Television (6,142)
    • US News (6,486)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    6 Golden Age Westerns To Watch On Prime Video (That Dont Star John Wayne)

    November 15, 2026

    Watch Travis Barker and Cynthia Erivo perform In The Air Tonight as Phil Collins tells Rock & Roll Hall Of Fame: You havent heard the last of me

    November 15, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT